Suro Senen

The Invisible Perfection: How Eye-Tracking Technology Is Redefining Facial Aesthetics

• Breast Cancer Surgery and Reconstruction

The Invisible Perfection: How Eye-Tracking Technology Is Redefining Facial Aesthetics

Suro Senen September 28, 2026

In the intricate world of cosmetic surgery, the nose has long been considered the centerpiece of the...

Read More Read more about The Invisible Perfection: How Eye-Tracking Technology Is Redefining Facial Aesthetics

Navigating the Storm: Tina’s Journey with Stage 3C Triple-Negative Breast Cancer and the Indispensable Role of Patient Navigators

• Patient Advocacy and Support

Navigating the Storm: Tina’s Journey with Stage 3C Triple-Negative Breast Cancer and the Indispensable Role of Patient Navigators

Suro Senen September 28, 2026

Arcata, California – August 25, 2025 – A seemingly ordinary Monday morning in September 2024 took a...

Read More Read more about Navigating the Storm: Tina’s Journey with Stage 3C Triple-Negative Breast Cancer and the Indispensable Role of Patient Navigators

Resilience, Radical Acceptance, and the Art of Living: The Story of Mark and Shanti

• Integrative Oncology and Holistic Care

Resilience, Radical Acceptance, and the Art of Living: The Story of Mark and Shanti

Suro Senen September 27, 2026

In the bustling, rapidly evolving landscape of San Francisco, where the digital gold rush often obscures the...

Read More Read more about Resilience, Radical Acceptance, and the Art of Living: The Story of Mark and Shanti

The Metabolic Frontier: Engineering the Future of Multifunctional Peptide Therapeutics

• Treatment Innovations

The Metabolic Frontier: Engineering the Future of Multifunctional Peptide Therapeutics

Suro Senen September 27, 2026

The pharmaceutical landscape is currently undergoing a paradigm shift. Driven by the meteoric commercial and clinical success...

Read More Read more about The Metabolic Frontier: Engineering the Future of Multifunctional Peptide Therapeutics

The Shadow of Automation: Australia Investigates OpenAI Breach in Landmark AI Security Case

• Treatment Innovations

The Shadow of Automation: Australia Investigates OpenAI Breach in Landmark AI Security Case

Suro Senen September 27, 2026

The rapid integration of artificial intelligence (AI) into the bedrock of modern public infrastructure has hit a...

Read More Read more about The Shadow of Automation: Australia Investigates OpenAI Breach in Landmark AI Security Case

Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis

• Survivorship and Post-Treatment

Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis

Suro Senen September 27, 2026

This article was developed in collaboration with Gina Franco, MSN, NP-C, Dip ACLM, Director of the Center...

Read More Read more about Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis

A Landmark Victory: NHS England Approves Enhertu for HER2-Low Metastatic Breast Cancer

• Clinical Oncology Education

A Landmark Victory: NHS England Approves Enhertu for HER2-Low Metastatic Breast Cancer

Suro Senen September 27, 2026

In a decision hailed as a transformative moment for oncology care in the United Kingdom, the National...

Read More Read more about A Landmark Victory: NHS England Approves Enhertu for HER2-Low Metastatic Breast Cancer

Balancing Science and Politics: Dr. Heidi Overton’s Path to the FDA Commissioner’s Chair

• Treatment Innovations

Balancing Science and Politics: Dr. Heidi Overton’s Path to the FDA Commissioner’s Chair

Suro Senen September 26, 2026

As the U.S. Food and Drug Administration (FDA) looks to emerge from a period of profound institutional...

Read More Read more about Balancing Science and Politics: Dr. Heidi Overton’s Path to the FDA Commissioner’s Chair

The Great Divergence: Novo Nordisk’s Market Correction and the AI Biotech Gold Rush

• Treatment Innovations

The Great Divergence: Novo Nordisk’s Market Correction and the AI Biotech Gold Rush

Suro Senen September 26, 2026

By Gwendolyn Wu | Sept. 25, 2026 The pharmaceutical landscape is currently defined by a tale of...

Read More Read more about The Great Divergence: Novo Nordisk’s Market Correction and the AI Biotech Gold Rush

Dialybrid Secures €15m to Pioneer Silk-Hybrid Vascular Access Technology

• Treatment Innovations

Dialybrid Secures €15m to Pioneer Silk-Hybrid Vascular Access Technology

Suro Senen September 23, 2026

Italian medical technology innovator Dialybrid has marked a pivotal moment in the evolution of nephrology and vascular...

Read More Read more about Dialybrid Secures €15m to Pioneer Silk-Hybrid Vascular Access Technology